AsymiLink Meta builds clinical decision support systems powered by artificial intelligence that assist physicians with diagnostic reasoning, treatment protocol adherence, and evidence-based care recommendations. Our CDS solutions integrate directly into clinical workflows through EHR-embedded alerts, CDS Hooks, and ambient intelligence layers that enhance rather than interrupt the clinician experience.
Our diagnostic assistance models analyze patient presentations including symptoms, lab results, imaging findings, and medication history against continuously updated clinical knowledge bases. The system surfaces differential diagnoses ranked by probability, highlights critical findings that may be overlooked in complex cases, and achieves a 31% improvement in diagnostic accuracy across validated clinical scenarios in internal medicine and emergency departments.
Protocol adherence monitoring tracks clinical actions against evidence-based care pathways for conditions including sepsis, stroke, acute coronary syndrome, and diabetic ketoacidosis. Real-time gap detection identifies when ordered interventions deviate from recommended timelines or when critical steps are missing, providing non-intrusive nudges that keep care teams aligned with best-practice protocols without generating alert fatigue.
Our AI models incorporate pharmacogenomic data, renal and hepatic function parameters, and current medication profiles to provide personalized dosing recommendations and drug interaction warnings. Unlike traditional rule-based alert systems that generate excessive overrides, our machine learning approach reduces clinically insignificant alerts by 67% while maintaining sensitivity to genuinely dangerous interactions and contraindications.
The knowledge management layer continuously ingests and synthesizes medical literature, clinical practice guidelines, FDA safety communications, and institutional formulary updates. Clinicians receive contextually relevant evidence summaries at the point of care, eliminating the need to search external databases during time-critical clinical encounters and ensuring treatment decisions reflect the most current medical evidence.
AsymiLink Meta clinical decision support systems are developed and validated in compliance with FDA guidance on clinical decision support software, HIPAA privacy and security requirements, and institutional clinical governance frameworks. Our SOC 2 Type II certified infrastructure ensures patient data used in CDS algorithms remains fully protected throughout processing, storage, and transmission.